🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
The purpose of the study is to investigate the safety, tolerability, and pr...
Status
Unknown
Location
Urologie Planegg
Start Date
2020-07-07
Trial ID
NCT04819399
Treatments Being Tested
OBJECTIVES: I. Assess the effect of immunosuppression with muromonab-CD3, ...
Status
Completed
Location
Mayo Clinic
Start Date
1999-12
Trial ID
NCT00004482
Treatments Being Tested
The purpose of the study is to assess the safety and tolerability of daily ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00630643
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-03-08
Trial ID
NCT01022138
Treatments Being Tested
DEFEND-2 is a Phase 3 confirmatory study for the Phase 3 DEFEND-1 study. Th...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-17
Trial ID
NCT01123083
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2019-05-20
Trial ID
NCT03524261
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested